Sandoz Group AG
Research Sandoz Group AG (D8Y0) on Bullrun: market cap EUR 32.67B, P/E 59.4, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerD8Y0
- ExchangeF
- CountrySwitzerland
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 32.67B
- P/E59.4
- Dividend yield1.2%
- Financial periodFY2025
- RevenueUSD 11.16B
- Revenue growth7.4%
- Net incomeUSD 914.00M
- Free cash flowUSD 810.00M
- Gross margin47.4%
Valuation Snapshot
latest market cap is EUR 32.67B; P/E is 59.4; dividend yield is 1.2%.
Peer valuation comparison
Latest P/E is 59.45x versus a Healthcare sector median of 24.46x (143.0% above).
Latest dividend yield is 1.2% versus a Healthcare sector median of 2.11% (43.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 11.16B | USD 914.00M | USD 810.00M | 47.4% | 2.09 | USD 1.74B | USD 5.68B | USD 9.38B |
| FY2024 | USD 10.38B | USD 0 | USD 60.00M | 47.4% | 0 | USD 1.19B | USD 4.85B | USD 8.16B |
| FY2023 | USD 9.98B | USD 77.00M | -USD 263.00M | 45.7% | 0.18 | USD 1.11B | USD 4.55B | USD 8.65B |
| FY2022 | USD 9.31B | USD 848.00M | USD 796.00M | 47.0% | 1.97 | USD 74.00M | USD 333.00M | USD 8.75B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 32.67B | 59.4 | 1.2% | 0.88 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.88 EUR, yield 1.2%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.64 USD |
| FY2024 | 0.43 USD |
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sandoz Group AG's market cap?
Sandoz Group AG's market capitalization is EUR 32.67B.
What is Sandoz Group AG's P/E ratio?
Sandoz Group AG's price-to-earnings (P/E) ratio is 59.4.
Does Sandoz Group AG pay a dividend?
Sandoz Group AG has a dividend yield of 1.2%.
What does Sandoz Group AG do?
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.